Illicium brevistylum
Illicium brevistylum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Illicium brevistylum is a unique botanical species recognized for its significant medicinal potential. Researchers have identified that the plant's roots possess notable antiviral activities that warrant further investigation. By focusing on specific preparations of these roots, scientists aim to harness their natural defense mechanisms against various pathogens. This plant serves as a vital subject in the study of traditional herbal remedies and modern pharmacology. Understanding the properties of Illicium brevistylum provides valuable insights into developing new therapeutic applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Schisandraceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Illicium brevistylum is a distinctive species widely recognized by its Chinese common name, 短柱八角. This plant belongs to the closely related star anise family, sharing structural similarities with many other aromatic shrubs. As a member of the Illicium genus, it maintains a unique botanical identity through its specific floral and carpel characteristics. Understanding these taxonomic connections helps gardeners and botanists appreciate its place within the broader plant kingdom. By studying its lineage, one can better grasp the evolutionary traits that define this unique species.
Sources: Catalogue of Life (COL)
Taxonomy
Illicium brevistylum is a distinctive member of the kingdom Plantae that showcases the intricate diversity of the natural world. Belonging to the class Equisetopsida, this species is classified under the order Austrobaileyales. Within this botanical framework, it is a specialized representative of the family Schisandraceae. It further defines its lineage through its placement in the genus Illicium. Together, these taxonomic relationships highlight the specific evolutionary position of this unique plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Austrobaileyales |
| Family | Schisandraceae |
| Genus | Illicium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Illicium brevistylum is a notable plant species primarily found within the Asia-Temperate region. Its geographic footprint is most concentrated across various parts of China, highlighting its regional importance. Specifically, the species thrives in the diverse environments of China South-Central. Additionally, its natural distribution extends into the lush landscapes of China Southeast. This specific range underscores the plant's specialized ecological niche within the Chinese landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Illicium brevistylum has shown significant potential in pharmacological research due to its diverse chemical profile. Scientists have successfully isolated several prenylated C6-C3 derivatives from the roots of this plant, including both known and previously undescribed compounds. These isolates were subjected to rigorous testing to evaluate their biological properties, specifically focusing on their antiviral and anti-inflammatory capabilities. Results indicated that certain compounds, such as 1-2, 5, and 7-8, exhibit moderate antiviral activity against the Coxsackievirus B3. Furthermore, the study confirmed that these extracts maintain a favorable safety profile by showing no significant cytotoxicity against various human cell lines.
Compounds
Conditions
Illicium brevistylum contains bioactive compounds that demonstrate antiviral activity against Coxsackievirus B3 (CVB3). These derivatives specifically treat Coxsackievirus B3 by exhibiting moderate to weak inhibitory effects. Additionally, the plant displays antiviral activity against the influenza virus A/Hanfang/359/95 (H3N2) strain. Beyond its antiviral properties, Illicium brevistylum also impacts nitric oxide (NO) generation in lipopolysaccharide-stimulated murine RAW264.7 macrophages. This interaction provides significant anti-inflammatory potential through the inhibition of NO production.
Preparations
Illicium brevistylum is prepared as roots to extract various antiviral prenylated C6-C3 derivatives. Researchers isolated nine specific compounds, including five previously undescribed structures, directly from these root portions. Through extensive spectroscopic analysis, the chemical structures and absolute configurations of these isolates were meticulously determined. The extracted components were then evaluated for their ability to combat viruses like Coxsackievirus B3 and influenza. Ultimately, these root-derived compounds demonstrated moderate antiviral activity and weak anti-inflammatory effects without significant cytotoxicity.
Parts used
Illicium brevistylum serves as a significant source of bioactive chemical compounds, particularly within its root system. Recent scientific investigations have successfully isolated several prenylated C6-C3 derivatives from these roots. These specialized metabolites, including both newly discovered and known structures, demonstrate various pharmacological properties. Specifically, the compounds extracted from the plant's roots have shown potential antiviral activity against Coxsackievirus B3 and influenza viruses. Furthermore, research indicates that these root-derived derivatives possess notable anti-inflammatory effects by inhibiting nitric oxide production in specific cell lines.